Atreca Inc Stock Return On Asset
Atreca Inc fundamentals help investors to digest information that contributes to Atreca's financial success or failures. It also enables traders to predict the movement of Atreca Pink Sheet. The fundamental analysis module provides a way to measure Atreca's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atreca pink sheet.
Atreca |
Atreca Inc Company Return On Asset Analysis
Atreca's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Atreca Return On Asset | -0.51 |
Most of Atreca's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atreca Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Atreca Inc has a Return On Asset of -0.512. This is 94.15% lower than that of the Biotechnology sector and 97.83% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Atreca Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atreca's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Atreca could also be used in its relative valuation, which is a method of valuing Atreca by comparing valuation metrics of similar companies.Atreca is currently under evaluation in return on asset category among its peers.
Atreca Fundamentals
| Return On Equity | -1.83 | |||
| Return On Asset | -0.51 | |||
| Current Valuation | (17.08 M) | |||
| Shares Outstanding | 38.41 M | |||
| Shares Owned By Insiders | 2.73 % | |||
| Shares Owned By Institutions | 24.54 % | |||
| Number Of Shares Shorted | 272.73 K | |||
| Price To Earning | (3.53) X | |||
| Price To Book | 0.28 X | |||
| EBITDA | (76.42 M) | |||
| Net Income | (97.76 M) | |||
| Cash And Equivalents | 101.73 M | |||
| Cash Per Share | 2.64 X | |||
| Total Debt | 63.88 M | |||
| Debt To Equity | 0.57 % | |||
| Current Ratio | 8.14 X | |||
| Book Value Per Share | 0.27 X | |||
| Cash Flow From Operations | (65.08 M) | |||
| Short Ratio | 0.16 X | |||
| Earnings Per Share | (2.50) X | |||
| Target Price | 5.5 | |||
| Number Of Employees | 90 | |||
| Beta | 1.17 | |||
| Market Capitalization | 3.02 M | |||
| Total Asset | 155.03 M | |||
| Retained Earnings | (456.92 M) | |||
| Working Capital | 61.73 M | |||
| Current Asset | 60.02 M | |||
| Current Liabilities | 3.56 M | |||
| Z Score | -5.25 | |||
| Net Asset | 155.03 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Atreca Pink Sheet
If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |